SLXNSilexion Therapeutics Corp同业对比
Silexion Therapeutics Corp 与Biological Products, (No Diagnostic Substances)的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 (Biological Products, (No Diagnostic Substances))| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SLXN本股 | $841267#9 | 0.0x#2 | 19.1x#6 | — | — | 27.9%#5 | — | -27072.7%#5 | — | — | -99.5%#13 | — |
| CELZ | $4M#2 | — | 0.5x#1 | 681.2x#6 | -45.5%#6 | -9.1%#9 | -102380.2%#9 | -69.3%#1 | -66.1%#1 | 3#2 | -79.8%#8 | — |
| LIMNW | $4M#3 | — | 12.5x#5 | — | — | -187.8%#11 | — | -3395.2%#4 | -170.3%#3 | — | -59.9%#7 | — |
| BCAB | — | — | — | — | — | 14.6%#7 | -19768.3%#7 | — | — | — | -94.5%#10 | — |
| ESLAW | $3M#4 | — | — | — | — | — | — | — | — | — | -19.7%#5 | — |
| CEROW | $3M#5 | — | — | — | — | — | — | — | — | — | 145.3%#2 | 4.9%#1 |
| CRIS | $2M#6 | 0.1x#5 | 0.5x#2 | 0.3x#2 | -13.4%#5 | 82.5%#1 | -60.5%#2 | -161.5%#2 | -87.3%#2 | — | -96.2%#11 | — |
| CLDI | $2M#8 | 0.0x#4 | 0.6x#3 | 43.1x#5 | — | 10.1%#8 | -44977.8%#8 | -635.4%#3 | — | — | -96.9%#12 | — |
| TVGNW | $526132#10 | — | — | — | — | -91.4%#10 | — | — | — | — | 86.2%#3 | — |
| VIVS | $2M#7 | — | — | 17.0x#4 | -9.0%#4 | -456.4%#13 | -8768.7%#6 | — | — | — | -93.3%#9 | — |
| SCLXW | $356706#11 | — | — | 0.0x#1 | -46.5%#7 | -413.8%#12 | -1143.7%#3 | — | — | 4#1 | 382.5%#1 | — |
| ABPWW | $116152#12 | 0.0x#3 | — | 0.6x#3 | 50.0%#2 | 60.0%#2 | -4618.6%#4 | — | — | — | -19.3%#4 | — |
| SLXNW | $99529#13 | 0.0x#1 | 2.3x#4 | — | — | 27.9%#5 | — | -27072.7%#5 | — | — | -53.0%#6 | — |
| ABPO | — | — | — | — | 50.0%#2 | 60.0%#2 | -4618.6%#4 | — | — | — | — | — |
| ADAPY | — | — | — | — | 195.3%#1 | 37.8%#4 | -38.6%#1 | — | — | — | — | — |
| AGMB | $234M#1 | — | — | — | — | — | — | — | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 数据构建于 2026-11-05。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议